MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MANNATECH INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.74+1.62 (+22.67%)
Close on Oct 19, 2026
- Market cap
- $16.87M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.02 (+0.23%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MANNATECH INC saw revenue fall 5.0% to $107.36M over the twelve months to Jun 30, 2026. Free cash flow was $1.60M.
Revenue
$107.36M
-5.0% vs. a year earlier
Operating income
$2.67M
TTM Q2 2026
Free cash flow
$1.60M
TTM Q2 2026
EPS, diluted
-$3.91
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $16.87M
- P/E ratio
- –
- Price to sales
- 0.16
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 9.46%
Fundamentals
- Revenue
- $107.36M
- Net income
- -$7.41M
- EPS, diluted
- -$3.91
- Free cash flow
- $1.60M
- Book value per share
- -$2.58
- Diluted shares
- 2M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$107.36M-5.0% YoY
Gross profit
$81.67M-4.6% YoY
Operating income
$2.67M
Net income
-$7.41M
EPS, diluted
-$3.91
Free cash flow
$1.60M
Reported periodTrailing twelve months